Skip to content

Prevalence Of Testosterone Deficiency In Patients With Chronic Obstructive Pulmonary Disease In King Chulalongkorn Memorial Hospital

Prevalence Of Testosterone Deficiency In Patients With Chronic Obstructive Pulmonary Disease In King Chulalongkorn Memorial Hospital

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
TCTR
Registry ID
TCTR20190301003
Enrollment
Unknown
Registered
2019-03-01
Start date
2018-01-10
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prevalence of testosterone deficiency in male COPD patients in King Chulalongkorn Memorial Hospital Chronic obstructive pulmonary disease Testosterone deficiency

Interventions

Male COPD patients who treated and followed up in King Chulalongkorn Memorial Hospital
Screening
COPD patients

Sponsors

Ratchadapisek Sompoch Endowment Fund, Faculty of Medicine, Chulalongkorn University
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
40 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. The 40-year or older male who was diagnosed of COPD by internist or pulmonologist. 2. The patients who give the informed consent and agree to follow to the study protocol.

Exclusion criteria

Exclusion criteria: 1. Underlying disease or history of these illnesses such as, 1.1 End stage renal disease which defined as creatinine clearance less than 15 ml/min/1.73 m2 1.2 Cirrhosis 1.3 History of active malignancy or recent chemotherapeutic medication within 5 years 1.4 Chronic anemia such as thalassemia who needed regular blood transfusion or finding of hemochromatosis 1.5 Active rheumatoid arthritis 1.6 Poor control of type 2 diabetes who have HbA1c > 8 % 1.7 Severe morbid obesity which defined as ≥ 30 kg/m2 1.8 Acute myocardial infarction or chest pain or dyspnea within 1 year 2. Diagnosed of hypogonadism before the inclusion period 3. Stop testosterone supplement and advice the patients to use as needed 4. Withdraw from the target 5. After acute exacerbation or admission who got systemic corticosteroid within 4 months 6. Available for listening, reading, or speaking in English 7. Contraindications of 6-minute walk test are 7.1 Acute myocardial infarction or chest pain (active) off prednisolone already 7.2 Systolic blood pressure > 180 mmHg or diastolic blood pressure > 120 mmHg and duration of pulse rate > 120 beat/min

Design outcomes

Primary

MeasureTime frame
Prevalence of testosterone deficiency in male COPD patients N/A Total testosterone level

Secondary

MeasureTime frame
N/A N/A N/A

Countries

Thailand

Contacts

Public ContactPanuwat Suteerayongprasert

Endocrine and metabolism division, Department of Medicine, King Chulalongkorm Memorial Hosptial

art_panuwat@Hotmail.com0855566797

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026